Dicyclomine Hcl
NDC Package 14789-010-02
Package Information
Dicyclomine Hcl is dicyclomine is used to treat a certain type of intestinal problem called irritable bowel syndrome. Marketed by Nexus Pharmaceuticals Llc, this product is identified by NDC 14789-010 and is authorized under FDA application ANDA206468.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 14789 - Nexus Pharmaceuticals Llc
- 14789-010 - Dicyclomine Hcl
- 14789-010-02 - 5 VIAL, SINGLE-DOSE in 1 CARTON / 2 mL in 1 VIAL, SINGLE-DOSE (14789-010-07)
- 14789-010 - Dicyclomine Hcl
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Billing & HCPCS Mapping
To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.
Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 14789-010-02 identifies a specific commercial package of 5 vial, single-dose in 1 carton / 2 ml in 1 vial, single-dose (14789-010-07) of Dicyclomine Hcl, labeled by Nexus Pharmaceuticals Llc. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Nexus Pharmaceuticals Llc on February 18, 2019. The current certification is valid through October 01, 2025.
What are the primary indications for this medication?
Dicyclomine is used to treat a certain type of intestinal problem called irritable bowel syndrome. It helps to reduce the symptoms of stomach and intestinal cramping. This medication works by slowing the natural movements of the gut and by relaxing the muscles in the stomach and intestines. Dicyclomine belongs to a class of drugs known as anticholinergics/antispasmodics. This medication must not be used in children younger than 6 months old because of the risk of serious side effects.
How is this Nexus Pharmaceuticals Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 14789001002. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.
